2010

Drug Management of Prostate Cancer

Editors:

ISBN: 978-1-60327-831-7 (Print) 978-1-60327-829-4 (Online)

Table of contents (37 chapters)

previous Page of 2
  1. Front Matter

    Pages i-xvii

  2. Cell Biology of Prostate Cancer and Molecular Targets

    1. Front Matter

      Pages 25-25

    2. No Access

      Book Chapter

      Pages 1-24

      Cell Biology of Prostate Cancer and Molecular Targets

  3. Hormone Therapy

    1. Front Matter

      Pages 25-25

    2. No Access

      Book Chapter

      Pages 27-39

      Luteinizing Hormone-Releasing Hormone and Its Agonistic, Antagonistic, and Targeted Cytotoxic Analogs in Prostate Cancer

    3. No Access

      Book Chapter

      Pages 41-51

      Nuclear Receptor Coregulators: Promising Therapeutic Targets for the Treatment of Prostate Cancer

    4. No Access

      Book Chapter

      Pages 53-59

      Androgens and Prostate Cancer

    5. No Access

      Book Chapter

      Pages 61-70

      Androgen Receptor Biology in Prostate Cancer

    6. No Access

      Book Chapter

      Pages 71-81

      Androgen Receptor Antagonists

    7. No Access

      Book Chapter

      Pages 83-89

      5-Alpha Reductase Inhibitors in Prostate Cancer

    8. No Access

      Book Chapter

      Pages 91-100

      Adrenal Androgen Synthesis Inhibitor Therapies in Castration-Resistant Prostate Cancer

    9. No Access

      Book Chapter

      Pages 101-107

      Androgen Deprivation Therapy

    10. No Access

      Book Chapter

      Pages 109-121

      Pharmacogenetics of the Androgen Metabolic Pathway

  4. Chemotherapy

    1. Front Matter

      Pages 123-123

    2. No Access

      Book Chapter

      Pages 125-131

      Mitoxantrone

    3. No Access

      Book Chapter

      Pages 133-146

      Docetaxel

    4. No Access

      Book Chapter

      Pages 147-151

      Beyond Docetaxel: Emerging Agents in the Treatment of Advanced Prostate Cancer

    5. No Access

      Book Chapter

      Pages 153-161

      Platinum Agents in Prostate Cancer

    6. No Access

      Book Chapter

      Pages 163-177

      Clinical Pharmacology and Pharmacogenetics of Chemotherapy in Prostate Cancer

    7. No Access

      Book Chapter

      Pages 179-194

      Microtubule Targeting Agents

  5. Angiogenesis

    1. Front Matter

      Pages 195-195

    2. No Access

      Book Chapter

      Pages 197-205

      Principles of Antiangiogenic Therapy

    3. No Access

      Book Chapter

      Pages 207-214

      Bevacizumab in Advanced Prostate Cancer

    4. No Access

      Book Chapter

      Pages 215-223

      Thalidomide and Analogs

    5. No Access

      Book Chapter

      Pages 225-232

      Investigational Angiogenesis Inhibitors

previous Page of 2